Milestone Pharmaceuticals Inc. (MIST) › Operating IncomeMilestone Pharmaceuticals Inc. (MIST) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$23.82M2019: -$57.88M2020: -$50.71M2021: -$43.07M2022: -$59.64M2023: -$61.10M2024: -$42.10M2025: -$62.14M-$62.14M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$62.14M-47.6%2024-$42.10M+31.1%2023-$61.10M-2.4%2022-$59.64M-38.5%2021-$43.07M+15.1%2020-$50.71M+12.4%2019-$57.88M-143.0%2018-$23.82M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share